Nanoneedles display potential in mediating the delivery of drugs and biologicals, as well as intracellular sensing and single cell stimulation through direct access to the cell cytoplasm. Nanoneedles enable cytosolic delivery, negotiating the cell membrane and the endolysosomal system, thus overcoming these major obstacles to the efficacy of nanotherapeutics. The low toxicity and minimal invasiveness of nanoneedles has a potential for the sustained nonimmunogenic delivery of payloads in vivo, provided that the development of biocompatible nanoneedles with a simple deployment strategy is achieved. Here we present a mesoporous silicon nanoneedle array that achieves a tight interface with the cell, rapidly negotiating local biological barriers to grant temporary access to the cytosol with minimal impact on cell viability. The tightness of this interfacing enables both delivery of cell-impermeant quantum dots in vivo and live intracellular sensing of pH. Dissecting the biointerface over time elucidated the dynamics of cell association and nanoneedle biodegradation, showing rapid interfacing leading to cytosolic payload delivery within less than 30 minutes in vitro. The rapid and simple application of nanoneedles in vivo to the surface of tissues with different architectures invariably resulted in the localized delivery of quantum dots to the superficial cells and their prolonged retention. This investigation provides an understanding of the dynamics of nanoneedles' biointerface and delivery outlining a strategy for highly local intracellular delivery of nanoparticles and cell-impermeant payloads within live tissues.
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nanoneedles; porous silicon; drug delivery; nanomedicine; biointerface; pH sensing; Quantum Dots Vertical arrays of nanoneedles can provide access to the cell cytosol and interact with the intracellular environment without eliciting toxicity or altering cell metabolism. [1] [2] [3] [4] Recent advances have indicated that nanoneedles may outperform currently available technology for the delivery of nucleic acids 3, 5, 6 and for the intracellular recording and stimulation of excitable cells. 7 However the widely employed interfacing (i.e., nanoinjection) strategies, while suitable for nanoinjection in culture, possess limited translational potential in vivo. 4, [7] [8] [9] Nanoinjection requires cell activity, 10, 11 centrifugation, 12 AFM operation 13 or electroporation 14 in order to guarantee intracellular interaction. Cell activity is highly dependent on cell type and its environment, and requires prolonged interfacing; 1 electroporation is accompanied by high cytotoxicity and immune response, 15, 16 while centrifugation and AFM operation are only applicable to cultures.
Semiconducting nanowires 3, 17 and carbon nanofibers/nanotubes 4, 18 constituting the vast majority of nanoneedles are not biodegradable and have demonstrated poor in vivo biocompatibility. Carbon nanowires can exhibit high cytotoxicity by multiple exposure routes and targeting different organs, 19, 20 leading to diverse pathologies including acute inflammation, 21 foreign body response 22 and cancer. 23 These effects can be mitigated during synthesis 22, 23 or before deployment 24 but safety concerns remain, especially when envisioning a minimally invasive, non-immunogenic treatment. Silicon is a poor biomaterial eliciting thrombus formation in contact with blood 25, 26 and foreign body response subcutaneously. 27 On the other hand porous silicon (pSi) is a viable candidate for the fabrication of biocompatible nanoneedles. It is a biodegradable 28 and highly biocompatible material, 29 employed in vivo for ocular implants, 30 as drug delivery vector particulate for intravenous injection 8, 31, 32 and tested in humans as a brachytherapy device. 33 Porous silicon nano-and microparticles uptake studies in culture have demonstrated elevated cytocompatibility following internalization. 31 Intravenously delivered pSi in vivo can distribute across all organs in the body 8, 34 and be cleared within few weeks, 8 without causing adverse reactions or eliciting inflammation. 32, 35 Indeed pSi use in humans has been evaluated as safe and risk-free in phase I and phase II clinical trials. 33, 36 Further development of nanoneedle technologies requires a more critical comprehension of the process of nanoinjection in both isolated cells and whole tissues to improve design and engineer nanoneedles with optimal nanoinjection potential. Still very little is known regarding the dynamics and localization of nanoneedles and their payload upon interfacing with cells. The very penetration of nanoneedles across the cell membrane is hotly debated. 1, 3, 37, 38 A growing body of evidence indicates that in vitro nanoinjection enables the crossing of the membrane barrier and allows for the direct colocalization with intracellular organelles and cytosolic structures. [1] [2] [3] 5, 13 The sudden drop in force that occurs when applying a nanoneedle, has been interpreted as the crossing of a physical barrier, the cellular membrane. 13 Confocal microscopy reveals that nanoneedles are often co-localized with the cytosol or nucleus. 3 In addition, nanoneedles can effectively deliver labile biological therapeutic agents in their active form to the nucleus and/or the cytosol, confirming their ability to efficiently reach the intracellular space. 1, 3 The buildup of large forces at the interface between the cell membrane and the high aspect ratio needle structure, has recently been proposed as the mechanism leading to self-puncturing and cytosolic display, 39 with self-puncturing being directly observed in mammalian cells. 10 Conflicting evidence suggests that nanoneedles may simply be tightly associated to the cell membrane, but not cross it completely. For example, the perinuclear fluorescent signal often associated with nanoneedle mediated delivery implies that a large portion of the payload was internalized through a classic endocytic pathway. 3 Furthermore sensing of intracellular electrical activity in several instances requires the initial application of a voltage pulse, to first induce membrane poration. 37 Electron microscopy imaging of in vitro nanoinjection reveals that short nanopillars of solid silicon appear unable to cross the plasmalemma. 38 Longer thinner nanowires instead, can significantly invaginate the plasma membrane 40, 41 or be internalized by the endolysosomal system as isolated broken fragments. 42 Little is known about the impact and cytotoxicity of nanoneedles inserted within cells and tissues; however cells grown over nanoneedles present unaltered respiratory metabolism, membrane integrity, proliferation, and housekeeping gene expression. 1 Nanoinjection has the unique potential to deliver nanoparticles to a specific set of cells in a localized region, without involving the vast majority of the tissue. The study reported here employs our recently developed class of porous silicon nanoneedles 6 to investigate their biointerface and the cytosolic delivery of nanoparticles. These porous silicon nanoneedles negotiate the endolysosomal system allowing sensing intracellular pH without inducing apoptosis. Dissecting the kinetics of the nanoneedles' interface and of quantum dots delivery yields insight into their cytosolic interaction and any nuclear envelope remodeling. The kinetic study also highlights the similarities and differences in interfacing and delivery existing between forceful nanoinjection compared to the seeding of cells over nanoneedles. Finally nanoinjection in mice demonstrates localized delivery of nanoparticles to the superficial layers of architecturally different mammalian tissues. The evolution of the nanoneedle biointerface and the dynamics of payload delivery are studied and the nanoneedles are applied as a system for the localized two-dimensional delivery of nanoparticles to the cell in live tissues of widely different architectures.
Results

Porous Silicon Nanoneedles
The synthesis of pSi nanoneedle arrays (nanoneedles) combined microfabrication with metal assisted chemical etching. The needles were arranged in a square lattice with 2 μm pitch, were 5-7 μm tall, had a tip diameter <50 nm, a 600 nm base and 50% porosity with 10-15 nm pore size (Figure 1 a) . A single process yielded a 100 mm wafer uniformly covered with needles. Photolithography followed by reactive ion etch defined the desired pattern on a thin film of low stress nitride over the silicon substrate (Figure 1 b) . Electroless deposition formed dendritic Ag nanoparticles selectively on the exposed silicon between the patterned areas. Metal assisted chemical etch of this substrate 43 yielded pSi pillars which reactive ion etching shaped into conical nanoneedles. This high throughput and parallelized fabrication strategy did not require direct writing and granted control over the geometry, arrangement, and nanoscale porosity of the needles.
In pursuing optimal biocompatibility and interfacing, our design choices were informed by the available literature and by our experience with pSi nanomaterials. A smaller tip diameter provides a tighter cell-needle interface 38 and favors the delivery of drugs across the cell membranes while reducing cytotoxicity. 1, 9, 13 Our previous investigations of pSi microparticles for systemic drug delivery indicated that a 10 nm pore size enabled optimal loading of hydrophilic quantum dots with 6 nm diameter 44 while the 50% porosity provided a 600-fold increase in surface area over solid structures and allowed full degradation within a day. 45
Nanoinjection provides safe intracellular interfacing and delivery
Nanojection was performed either by seeding cells over an array of nanoneedles (nanoneedles on bottom, nN-B), or by forcibly applying the nanoneedles from the top of the cell monolayer (nanoneedles on top, nN-T). Forcible application employed a centripetal acceleration of 100 rcf on a 70 mg chip, leading to an effective force of 68 mN shared across the 1.6 × 10 7 nanoneedles present on the chip, effectively applying a theoretical load of 4.25 nN per needle. This force is compatible with nanoneedle intracellular penetration, being higher than the threshold identified for a nanoneedle to cross a plasma membrane (0.5nN to 2nN). 9 We have previously observed that nanoinjection does not affect viability or proliferation of cells. 6 A pH sensor was built by covalent attachment of a pH-sensitive fluorophore (fluorescein isothiocyanite, FITC) and a reference fluorophore (AlexaFluor 633, AF633) to the nanoneedles. The response of this sensor to pH was measured by ratiometric fluorescence and was found to be linear in the biologically relevant range of pH (6.1 to 7.9, Figure S1 ). Upon nanoinjection in vitro, this sensor mapped intracellular pH (pHi) with single cell resolution alongside extracellular pH (pHe). The OE33 oesophageal adenocarcinoma cell line displayed significant quenching of FITC fluorescence in correspondence of most nanoneedles underlying cells, corresponding to a ratiometric measurement of pH 6.7 ( Figure  2 a, c, d). Conversely the nanoneedles tested with HET-1A cells displayed a ratiometric fluorescence equivalent to pH 7.2 (Figure 2 b, c, d). Both findings were in agreement with the pHi measured for OE33 and HET-1A by BCECF ( Figure S2 ). The pH 7.4 measured for free standing nanoneedles was consistent to the pHe of the culture medium (Figure 2c, d) . In OE33 cultures, a red nanoneedle would be sensing a pH equivalent to pHi, while a yellow/ green one would be sensing pHe. Upon nanoinjection the vast majority of nanoneedles underlying OE33 cells sensed pHi (Figure 2 
Europe PMC Funders Author Manuscripts
Europe PMC Funders Author Manuscripts intracellular delivery and sensing appeared to have a minimal impact on cell viability, as evidenced by the few apoptotic cells in Figure 2 e (green nuclei indicated by blue arrows).
Exploring the cell-nanoneedle interface
Following nanoinjection, confocal microscopy revealed intact nanoneedles interfaced to the cytosol of cells. Several nanoneedles co-localized with the nuclear region regardless of injection strategy (Figure 3 a-e). In agreement with the pHi measurements, confocal microscopy suggested a tight cytosol-nanoneedle interface, showing nanoneedles several hundreds of nanometers above the red membrane staining, but could not provide detailed information regarding their interaction with subcellular structures (i.e. cytoskeleton, vesicles, etc.) or their mutual positioning with respect to the nucleus.
To visualize the cell-nanoneedle interface at higher resolution, we processed the cells using a slice-through imaging approach combined with dual beam Focused Ion Beam-Scanning Electron Microscopy (FIB-SEM) (Figure 3 b,e, Movies S1-S8). In agreement with the nanoneedles' ability to sense pHi, FIB-SEM suggested that nanoneedles tightly interfaced with the cytosol (Figure 3 b,e, Figure S3 ). Several nanoneedles seemed to be pinned to the nucleus, with the nuclear envelope being remodeled to wrap around each nanoneedle ( Figure  S4 , Movies S3, S7). Importantly, the needles localizing within the non-nuclear areas of the cell never appeared to emerge from the far side of the cell (Figures S3, S5 , Movies S1-S3, S5-S7). Regardless of the nanoinjection strategy (nN-B or nN-T), cells exhibited flexible nuclear and plasma membrane rearrangements in response to the puncturing needle.
Confocal microscopy and SEM-FIB analysis showed that as early as one hour after seeding, the tip of the nanoneedles appeared to interface with the cytosol and in close proximity to the nucleus (Figure 3 d-i, Figure S6 a, Movie S1). Quantification of segmented SEM-FIB images confirmed that the needles progressively increased their interfacing with the cytosol while reducing their distance to the nucleus (Figure 3 h, i). After 8 hours the nanoneedles interfaced with the cytosol for a depth of 2 μm and appeared to have contacted the nuclear envelope, inducing nuclear remodeling (Figure 3 e, g-i, Movies S1-S8). Immediately after seeding, cells retained the typical spherical shape of the early stages of cell spreading (figure 3 d-g, Movies S1, S2). At later time points, the cells continued to extend and spread, wrapping the tips of their filopodia to the neighboring needles ( Figure S6 ).
Throughout the process of interfacing the nanoneedles experienced progressive degradation, effectively increasing their porosity and reducing their mechanical stability. Inspection of the nanoneedles 8 hours after injection revealed they retained their morphology. After 15 hours, nanoneedles were visibly degraded ( Figure S7 ) until only the solid stump of the needles remained by 72 hours. At this time no recognizable nanostructure resembling the nanoneedles could be found within the cells. (Figure 3 d-g, Figure S8 , Movies S4, S8). The electron dense regions observed in the cytosol likely represent areas of high Si concentration that arose from the degradation of the nanoneedles (Figure 3 e, g, Movies S4, S8). Similarly, the confocal micrographs of nanoneedles covalently-tagged with a fluorescent dye displayed intracellular regions of green fluorescence, likely originating from the dye initially conjugated to the needles (Figure 3 d) . 
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Cytosolic nanoinjection of quantum dots Fluorescent 6 nm hydrophilic quantum dots were loaded in the porous structure of the nanoneedles (Figure S9 a) and nanoinjected into cells. Confocal microscopy confirmed that quantum dots diffused rapidly throughout the cytosol of all cells (Figure 4 a-b ). SEM-FIB confirmed that quantum dots localized both on the nanoneedles and within the cytosol of nanoinjected cells, but not within the nucleus (Figure 4 c, Figure S10 ). Transmission electron microscopy coupled with elemental analysis validated the intracellular presence of quantum dots and their free accumulation in the cytosol outside of the membranous organelles constituting the endolysosomal system (Figure 4 d, Figure S11 ).
The same amount of quantum dots delivered in solution could not be detected intracellularly by SEM-FIB and generated limited fluorescence associated with the cell body (Figure 4 a,c) , thus confirming that the delivery of quantum dots was directly mediated by the nanoneedles. Both nN-B and nN-T showed cytosolic accumulation of quantum dots as early as 30 minutes following nanoinjection (Figure 4 b) and reached a plateau within 1 hour. nN-B samples retained 69% of the payload at 24 hours, compared to 18% of nN-T (Figure 4 a, b ). The delivery of quantum dots occurred more rapidly for nN-T, likely due to the earlier, deeper interfacing of the nN-T nanoinjection, which at 1 minute displayed a similar profile to nN-B at 8 hours ( Figure 2 ). While the average peak delivery was similar for the two approaches, nN-B delivery was more uniform across cells, especially at shorter times (Figure 4 a,b) . While the nN-T cells were adherent on the substrate for at least 24h prior to nanoinjection, the nN-B cells needed additional time to initially adhere and spread to the nanoneedles. In agreement with our prior observations during the exploration of the cell-nanoneedle interface, these results may reflect the more uniform and gradual interaction with the cytosol for the nN-B (Figure 4 a,b ).
Bovine serum albumin (BSA) and siRNA were simultaneously loaded into nanoneedles, showing uniform distribution throughout the entire porous matrix ( Figure S9 b-d) . In both nanoinjection strategies the BSA and siRNA payloads were delivered to the cytosol similarly to what was observed with quantum dots ( Figure S12 ).
Nanoinjection of quantum dots to muscle and skin
In vivo nanoinjection of quantum dots to an exposed muscle and two skin locations allowed evaluation of localized nanoparticle delivery in mice. Regardless of the tissue, quantum dots were confined to a limited volume associated with the surface layer contiguous to the site of nanoinjection ( Figure 5 a,b Figure S13 ). Quantum dot fluorescence was observed originating from the cytosolic region of cells located at the surface (Figure 5 a) , and TEM confirmed the presence of quantum dots associated with cells ( Figure 5 c) .
In skin and muscle, nanoinjection left a square fluorescent mark at the delivery site, which replicated the geometry of the nanoneedle chip ( Figure 5 d-f ). Further confirming delivery within the tissue, nanoinjected quantum dots were retained for up to 100 hours around the injection site ( Figure 5 f) . By comparison quantum dots delivered through a flat silicon chip completely dispersed in less than 24 hours ( Figure S14 ). 
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Discussion
Porous silicon nanoneedles can efficiently load a nanoparticle payload and direct its delivery to the cells in a localized superficial area of tissue. The nanoneedles' ability to sense intracellular pH and direct cytosolic delivery of different payloads (nanoparticles, dyes, proteins, nucleic acids) combined with the limited occurrence of apoptosis support the available literature to indicate the efficacy, minimal invasiveness, and safety potential of nanoinjection.
Nanoinjection of quantum dots to the cell cytosol occurred rapidly after interfacing with the cell. The nN-B nanoinjection relied on active cell processes for minimally disruptive intracellular delivery. Conversely nN-T proved to be a viable option for nanoinjection in vivo, as it delivered the payload to the cells' cytosol through a rapid and forcible interfacing. During nanoinjection the needles progressively interfaced with the cytosol while the cell nucleus remodeled to minimize or avoid interfacing. This display of active cellular movement subsequent to needle penetration was a further confirmation of the low impact of nanoneedles on cell metabolism.
The superficial intracellular delivery observed in vivo was extremely localized to the area interfaced by the needles and did not reach the bulk of tissues or cross tissue barriers such as the stratum corneum of the skin. The local nature of the interaction suggests that nanoneedles-mediated delivery or sensing would only occur at the immediate region of interfacing, with minimal involvement of the remaining tissue.
Microneedles typically require a high insertion velocity to deliver a payload in vivo. 46 Conversely our nanoinjection strategy has very low impact on the tissues while showing prolonged retention of the payload at the delivery site. The minimally invasive, uniform and controlled access to the cytosol of a large number of cells within a defined or patterned area, combined with the ability to deliver to and sense the intracellular space with the potential to discriminate cancer (OE33) from healthy (Het-1A) cellular microenvironment can pave the way towards nanoscale interaction and interrogation of cells within complex architectures for the assessment of tissue pathologies at the single cell level.
Methods
An expanded methods section covering the details of all methods employed in this study is available as supplementary material.
Nanoneedles fabrication
A layer of 160nm of low-pressure chemical vapour deposition low stress silicon nitride was deposited on boron doped p-type, 100 mm, 0.01 0.01 Ω-cm Si wafers. The photolithographic pattern consisting of 600 nm diameter disks with a 2 μm pitch was transferred on the photoresist coated substrate. Pattern transfer limited to the silicon nitride layer was performed by CF 4 reactive ion etching. The photoresist was then stripped.
Electroless deposition of Ag on the patterned Si wafer occurred in an HF solution of 0.02 M AgNO 3 20 ml 49% HF, 75 ml H 2 O, following the substrate cleaning in 10% HF. The
The pH images were analyzed in a custom Matlab program that identified the nanoneedles from the background and calculated the fluorescence emission ratio of FITC/AF633 singularly for each nanoneedle, and then averaged it over a pre-selected region of interest.
Nanoneedles on top interfacing in vivo
Animal studies were performed in accordance with the guidelines of the Animal Welfare Act and the Guide for the Care and Use of Laboratory Animals based on approved protocols by Houston Methodist Research Institute's Institutional Animal Care and Use Committees. APTES modified nanoneedles (supplementary materials) were thoroughly cleaned with ethanol and dried under UV and then loaded with 660 nm CdTe quantum dots (PlasmaChem GmbH). The solution was allowed to dry on the needles and then was immediately used for experiments. The loaded nanoneedles were imprinted on the skin (back or ear) and muscle of male athymic nude mice (n=3) (NCr-Fox1 nu ; 4-6 week old). Animals were anesthetized and directly nanoinjected in the case of skin. For muscle, the superficial gluteal and lumbar muscles were exposed by surgical incision, gently elevating the fascia from the underlying muscle. The nanoneedles were inserted in direct contact with the lumbar and gluteal muscle on the right side. Nanoneedles were removed within two minutes from the insertion. Mice were imaged using a Xenogen IVIS200 housed within the preclinical imaging core facility at HMRI. Mice were imaged at pre-determined times to study the release kinetics of quantum dots from the site of treatment. Data was quantified with Living Image 4.1.
Histology
Histological analysis for H&E and fluorescence imaging on muscle, skin, and ear was performed. Tissues were harvested and fixed in formalin prior to embedding into paraffin. Paraffin sections were then deparaffinized with xylene and re-hydrated with decreasing concentrations of ethanol followed by washings in water. Staining occurred immediately after this step either with H&E or with AF488 WGA and DAPI for fluorescence imaging of Qdots and then coverslipped. Furthermore, unstained sections of tissues were used to quantify quantum dot fluorescence. 
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Europe PMC Funders Author Manuscripts dense areas attributed to Si in green (72 hours). (h) Quantification of the nanoneedles depth of cytosolic interfacing, measured as the distance between the tip of the nanoneedle and the underlying cell membrane. (i) Quantification of the distance of nanoneedles from the nucleus, measured as the distance between the tip of a nanoneedle and the cell nucleus. *p<0.05, **p<0.01. 
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